The MyD88 deficiency in cardiomyocytes does not affect the systemic control of the parasite, as similar parasitemia curves were observed in tamoxifen-treated Mer+MyD88flox+/+ and MerCreMer+/+ mice. Here, MYD88 is linked to parasitic infectious disease.